Zobrazeno 1 - 4
of 4
pro vyhledávání: '"Menaka Dilani Samarawickrama Lokuhetty"'
Autor:
Indumini Maheshika Jinadasa, Harshima Disvini Wijesinghe, Modini Manohari Abeydera Jayawickrama, Menaka Dilani Samarawickrama Lokuhetty
Publikováno v:
Diagnostic Pathology, Vol 17, Iss 1, Pp 1-9 (2022)
Abstract Background The multistep molecular model of breast carcinogenesis is based on the oestrogen receptor(ER) status of the tumour. Its two main arms comprise ER-positive and ER-negative breast carcinomas(BCa), which are associated with Nottingha
Externí odkaz:
https://doaj.org/article/bd15af338c5c4be89ddda47124868803
Autor:
Harshima Disvini Wijesinghe, Gayani Kokila Wijesinghe, Zahara Mansoor, Sanjeev Vigneshwara, Janakie Fernando, Dehan Gunasekera, Menaka Dilani Samarawickrama Lokuhetty
Publikováno v:
BMC Women's Health, Vol 20, Iss 1, Pp 1-14 (2020)
Abstract Background Androgen receptor (AR) expression is emerging as a prognostic biomarker in breast carcinoma (BCa). The study aimed to determine the prevalence of AR expression by immunohistochemical analysis among a cohort of Sri Lankan women wit
Externí odkaz:
https://doaj.org/article/f9c2c3a9505e470ca4e565ae34aaa41c
Autor:
Indumini Maheshika Jinadasa, Harshima Disvini Wijesinghe, Modini Manohari Abeydera Jayawickrama, Menaka Dilani Samarawickrama Lokuhetty
Publikováno v:
Diagnostic pathology. 17(1)
Background The multistep molecular model of breast carcinogenesis is based on the oestrogen receptor(ER) status of the tumour. Its two main arms comprise ER-positive and ER-negative breast carcinomas(BCa), which are associated with Nottingham grade(N
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2382df1c6481e9f176ade328860a30d1
https://pubmed.ncbi.nlm.nih.gov/36581929
https://pubmed.ncbi.nlm.nih.gov/36581929
Autor:
Sanjeev Vigneshwara, J. Fernando, Dehan Gunasekera, Menaka Dilani Samarawickrama Lokuhetty, Zahara Mansoor, G. K. Wijesinghe, H. D. Wijesinghe
Publikováno v:
BMC Women's Health
BMC Women's Health, Vol 20, Iss 1, Pp 1-14 (2020)
BMC Women's Health, Vol 20, Iss 1, Pp 1-14 (2020)
Background Androgen receptor (AR) expression is emerging as a prognostic biomarker in breast carcinoma (BCa). The study aimed to determine the prevalence of AR expression by immunohistochemical analysis among a cohort of Sri Lankan women with early B
Externí odkaz:
https://explore.openaire.eu/search/publication?articleId=doi_dedup___::2a371ebe55a6a3f3f195c81de7b480cf
https://doi.org/10.1186/s12905-020-01068-5
https://doi.org/10.1186/s12905-020-01068-5